Challenging the FDA black box warning for high aspirin dose with ticagrelor in patients with diabetes.
DiNicolantonio JJ; Serebruany VL; Diabetes, 2013, vol. 62, issue 3, p 669, ISSN 1939327x. ISBN 1939327x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef